Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck-Reference-Cited by-全球学者库

Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck

Published:2019-08-01 Issue:8 Volume:5 Page:1170
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Burtness Barbara¹,Haddad Robert²,Dinis José³,Trigo José⁴,Yokota Tomoya⁵,de Souza Viana Luciano⁶,Romanov Ilya⁷,Vermorken Jan⁸,Bourhis Jean⁹,Tahara Makoto¹⁰,Martins Segalla José Getulio¹¹,Psyrri Amanda¹²,Vasilevskaya Irina¹³,Nangia Chaitali Singh¹⁴,Chaves-Conde Manuel¹⁵,Kiyota Naomi¹⁶,Homma Akihiro¹⁷,Holeckova Petra¹⁸,Del Campo Josep Maria¹⁹,Asarawala Nirav²⁰,Nicolau Ulisses Ribaldo²¹,Rauch Daniel²²,Even Caroline²³,Wang Bushi²⁴,Gibson Neil²⁵,Ehrnrooth Eva²⁶,Harrington Kevin²⁷,Cohen Ezra E. W.²⁸,

Affiliation:

1. Department of Medicine and Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut

2. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts

3. Instituto Português de Oncologia, Porto, Portugal

4. Department of Medical Oncology, Hospital Virgen de la Victoria, IBIMA, Malaga, Spain

5. Division of Gastrointestinal Oncology, Shizuoka Cancer Centre, Shizuoka, Japan

6. Department of Medical Oncology, Hospital Marcio Cunha, Ipatinga, Brazil

7. Russian Oncological Research Centre, Moscow, Russia

8. Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium

9. Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

10. Department of Head and Neck Medical Oncology, National Cancer Centre Hospital East, Kashiwa, Japan

11. Department of Clinical Oncology, Hospital Amaral Carvalho, Jau, Brazil

12. Department of Internal Medicine, National Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece

13. Oncology Centre of Moskovskiy, St Petersburg, Russia

14. Comprehensive Cancer Centre, University of California at Irvine, Orange

15. Department of Oncology, Hospital Virgen del Rocio, Sevilla, Spain

16. Department of Medical Oncology and Hematology, Kobe University Hospital Cancer Center, Kobe, Japan

17. Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan

18. Department of Oncology and Radiotherapy, Hospital Na Bulovce and 1st Medical Faculty of Charles University, Prague, Czech Republic

19. Department of Oncology, Vall d’Hebron University Hospital, Barcelona, Spain

20. Shree Krishna Hospital and Medical Research Centre, Gujarat, India

21. Department of Clinical Oncology, AC Camargo Cancer Center, São Paulo, Brazil

22. Inselspital, University Hospital Bern, Bern, Switzerland

23. Department of Head and Neck Cancer, Gustave Roussy, Villejuif, France

24. Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut

25. Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany

26. Boehringer Ingelheim, Danmark A/S, Denmark

27. Division of Radiotherapy and Imaging, The Royal Marsden Hospital/The Institute of Cancer Research, National Institute for Health Research Biomedical Research Centre, London, United Kingdom

28. Department of Translational Science, Moores Cancer Centre, University of California at San Diego, La Jolla

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/article-pdf/5/8/1170/17773660/jamaoncology_burtness_2019_oi_190031.pdf

Reference30 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.;Ferlay;Int J Cancer,2015

2. The chemoradiation paradigm in head and neck cancer.;Seiwert;Nat Clin Pract Oncol,2007

3. Comparison of survival outcomes among human papillomavirus-negative cT1-2 N1-2b patients with oropharyngeal squamous cell cancer treated with upfront surgery vs definitive chemoradiation therapy: an observational study.;Kelly;JAMA Oncol,2017

4. Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathologic residual carcinoma and prognosis.;Lango;Head Neck,2009